The S-Class W116 was the best selling luxury sedan of its time and the new W126 was designed to keep Mercedes-Benz in that position for years to come. The new series provided improved ride, better handling, more power and increased fuel efficiency over it predecessor the W116.he S-Class W116 was the best selling luxury sedan of its time and the new W126 was designed to keep Mercedes-Benz in that position for years to come. The new series provided improved ride, better handling, more power and increased fuel efficiency over it predecessor the W116.
Prostate cancer mainly affects men over 50, and your risk increases with age. The average age for men to be diagnosed with prostate cancer is between 65 and 69 years. If you are under 50, your risk of getting prostate cancer is very low. Men under 50 can get it, but it isnât common. If you're over 50 and you're worried about your risk of prostate cancer, you might want to ask your GP about tests for prostate cancer. If you're over 45 but have a higher risk of prostate cancer â because you have a family history of it or you're a black man â you might want to talk to your GP too.
Prostate cancer is the most common cancer among men, except for skin cancer. This year, an estimated 161,360 men in the United States will be diagnosed with prostate cancer. For unknown reasons, the risk of prostate cancer is 74% higher in black men than in non-Hispanic white men. Most prostate cancers (92%) are found when the disease is confined to the prostate and nearby organs. This is referred to as the local or regional stage. The 5-year survival rate tells you what percent of men live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for most men with local or regional prostate cancer is almost 100%. Ninety-eight percent (98%) are alive after 10 years, and 96% live for at least 15 years. For men diagnosed with prostate cancer that has spread to other parts of the body, the 5-year survival rate is 29%. Prostate cancer is the third leading cause of cancer death in men in the United States.